Request Your Free Data Sheet Now:

"Seraseq Blood TMB Mix Score 7, 13, 20, 26"

Tumor mutational burden, as measured by exome or panel sequencing of tumor tissue (tTMB) or blood (bTMB), has been identified as a potential predictive biomarker for treatment benefit in patients with various cancer types receiving immunotherapy targeting checkpoint pathways. However, significant variability in TMB measurement has been reported due to differences in preanalytical and laboratory methods, panel size, number of genes covered, and bioinformatics pipelines.
View full description >

Connect or Login with Email

Get Started

Welcome Back, ().
at

Has your work information changed?

Welcome
Please review the fields below for completeness and accuracy prior to submitting.

Welcome Back, ().
Has your work information changed?

Valid email address is required to fulfill your request.